These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28369276)

  • 1. Foreign body granuloma as an unexpected long-term finding after percutaneous closure of a patent foramen ovale.
    Besler C; Bakhtiary F; Linke A; Zimmer M
    Eur Heart J; 2017 Dec; 38(46):3472-3473. PubMed ID: 28369276
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatous mass adherent to a patent foramen ovale occluder.
    Ancedy Y; Bernard Brunet A; Quilliet L; Mirza A; Fauchier L
    Eur Heart J; 2013 Aug; 34(29):2251. PubMed ID: 23704707
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcatheter Closure of Patent Foramen Ovale.
    Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):ix-x. PubMed ID: 28886847
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
    Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device-Associated Left Atrial Thrombosis Despite Oral Anticoagulation After Percutaneous Patent Foramen Ovale Closure.
    Tzimas G; Muller O; Kirsch M; Monney P
    Can J Cardiol; 2019 Nov; 35(11):1605.e5-1605.e6. PubMed ID: 31679631
    [No Abstract]   [Full Text] [Related]  

  • 6. Unexpected perforation leading to life-threatening cardiac tamponade six years after patent foramen ovale closure with an intrasept device.
    Vandeloo B; Dymarkowski S; Budts W
    Acta Cardiol; 2016 Apr; 71(2):247-8. PubMed ID: 27090049
    [No Abstract]   [Full Text] [Related]  

  • 7. Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.
    Kransdorf EP; Kransdorf LN; Fortuin FD; Sweeney JP; Wilansky S
    Tex Heart Inst J; 2016 Apr; 43(2):171-4. PubMed ID: 27127438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
    Scacciatella P; Biava LM; Marra S
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous closure of patent foramen ovale in a patient with situs viscerum inversus.
    Mega S; Patti G; Gaspardone A; D'Ambrosio A; Picarelli S; Sarubbi D; Sedati P; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):168-70. PubMed ID: 22609870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Assessment of the Interatrial Septum for Transcatheter Atrial Septal Defect and Patent Foramen Ovale Closure.
    Bechis MZ; Rubenson DS; Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):505-524. PubMed ID: 28886842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiography vs transesophageal echocardiography-guided patent foramen ovale closure: A propensity score matched analysis of a two-center registry.
    Scacciatella P; Meynet I; Giorgi M; Biava LM; Matranga I; Biasco L; Omedè P; Orzan F; Gaita F
    Echocardiography; 2018 Jun; 35(6):834-840. PubMed ID: 29457261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous removal of unraveled HELEX® septal occluder 4 months post deployment.
    Suntharos P; Komarlu R; Prieto LR
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):115-20. PubMed ID: 25639512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance imaging and the WATCHMAN device.
    Hong SN; Rahimi A; Kissinger KV; Pedrosa I; Manning WJ; O'Halloran TD
    J Am Coll Cardiol; 2010 Jun; 55(24):2785. PubMed ID: 20538174
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
    Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
    Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous closure of patent foramen ovale with Atriasept II device in nickel allergic patients.
    Cammalleri V; Ussia GP; Marchei M; Muscoli S; Sergi D; Macrini M; Romeo F
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):350-2. PubMed ID: 24685961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
    Manolis AS; Koulouris S; Rouska E; Pyrros J
    Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent Foramen Ovale Closure for Hypoxemia.
    Tobis JM; Narasimha D; Abudayyeh I
    Interv Cardiol Clin; 2017 Oct; 6(4):547-554. PubMed ID: 28886845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder.
    Klotz S; Gebhard M; Sievers HH
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1270-1. PubMed ID: 21724200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.